Kiniksa Pharmaceuticals International, plc KNSA

Healthcare — Drug Manufacturers Specialty & Generic

75.08 (0.26) (0.35%) as of 25 Sep

Market cap: $5.9B
P/E: 70.2×

Follow KNSA

Growth Flags show if company had growth for consecutive years

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25
Cash and Short Term Investments	56.08	45.66	307.30	233.38	323.69	182.20	190.61	206.37	243.63	414.07
Receivables	—	—	—	—	—	3.99	12.66	21.27	41.72	15.59
Inventory	—	—	—	—	—	3.68	21.60	31.12	26.36	54.90
Other current assets	0.26	1.44	6.45	8.25	9.56	6.59	7.66	—	—	—
Total current assets	56.33	47.10	313.75	241.63	333.25	196.45	243.06	276.30	331.80	527.18
Property, Plant, Equpment (Net)	0.08	0.13	6.36	6.40	4.05	2.83	1.66	0.73	0.66	1.94
Goodwill and Intangible Assets (Total)	—	—	—	—	—	19.25	18.25	17.25	16.25	15.25
Long Term Assets (Tax, Deferred)	0.04	0.24	1.22	4.37	0.01	—	185.50	219.28	211.15	198.15
Long-term assets (Other)	0.01	0.03	0.21	0.21	5.59	8.72	5.82	0.83	10.32	11.31
Total non-current assets	0.13	0.39	8.22	12.91	16.22	36.35	216.61	250.03	248.75	236.46
Total Assets	56.47	47.49	321.97	254.53	349.46	232.80	459.67	526.32	580.55	763.63
Accounts Payable	0.21	1.22	10.92	5.69	0.50	1.87	7.90	8.25	2.04	2.03
Accrued Expenses	2.09	16.21	31.42	20.42	29.20	38.03	30.11	44.67	80.51	112.04
Current Revenue (Deferred)	—	—	—	—	—	—	—	0.31	—	—
Other current liabilities	2.09	16.21	0.22	0.03	0.04	1.54	5.75	8.19	16.08	22.13
Total current liabilities	2.30	17.43	42.55	27.83	31.85	44.82	47.07	63.67	100.62	139.18
Non-current Revenue (Deferred)	—	—	—	—	—	—	12.00	11.95	31.81	31.81
Non-current Liabilities (Other)	—	—	0.14	0.33	0.81	0.27	1.84	1.86	1.82	18.52
Total non-current liabilities	—	—	0.14	1.28	5.68	2.94	16.46	23.82	41.50	56.84
Total liabilities	2.30	17.43	42.70	29.11	37.53	47.76	63.52	87.48	142.12	196.03
Additional Paid In Capital	0.39	1.29	473.48	581.47	829.42	860.48	888.12	916.76	959.72	1,029.75
Preferred Stock (Total)	79.90	119.77	—	—	—	—	—	—	—	—
Common Stock (Net)	0.00	0.00	0.01	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Retained Earnings	(26.12)	(91.00)	(194.22)	(356.09)	(517.47)	(675.40)	(492.03)	(477.95)	(521.14)	(462.14)
Common Equity (Total)	(25.73)	(89.71)	279.27	225.42	311.94	185.04	396.15	438.84	438.44	567.61
Shareholders Equity (Total)	54.17	30.06	279.27	225.42	311.94	185.04	396.15	438.84	438.44	567.61
Shareholders Equity and Liabilities (Total)	56.47	47.49	321.97	254.53	349.46	232.80	459.67	526.32	580.55	763.63
Shares (Common)	48.44	4.29	49.49	54.94	68.22	69.06	69.70	70.46	72.52	76.29
Shares (Preferred)	17.13	22.89	—	—	—	—	—	—	—	—
Shareholders Equity (Tangible)	54.17	30.06	279.27	225.42	311.94	165.79	377.90	421.59	422.19	552.36
Net Debt	(56.07)	(45.66)	(307.30)	(233.38)	(323.69)	(182.20)	(190.61)	(206.37)	(243.63)	(414.07)
Total Debt	—	—	—	2.65	6.99	6.05	5.92	—	—	—

Show all line items

In millions of $ except per-share values · columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

Kiniksa Pharmaceuticals International, plc KNSA